EUVIMEDEUVIMED entdecken
BeobachtungsstudieFall-Kontroll-Studie

Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study.

Ihab Anwar Orabi, Ahmed A Elhadidy, Ola Abd Elfattah Ali Amro, Asmaa A Attia, Amr A Abdelkader, Elham Shabaan Mohamed, Mohammad Mossaad Abd Allah Alsayyad, Ahmed Fakeih Sakr Elfors, Marian Wagieh Mansour Abdelmalak, Sherif Mohamed Elsayed Amin Hegab, Tamer Hassan Rashwan, Hatem Attia Mostafa Ismail und 2 weitere

La Clinica Terapeutica · 01.09.2026 · 177 (5) · 1079-1085

DOI: 10.7417/ct.2026.2108 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift La Clinica Terapeutica, erschienen am 01.09.2026. Verfasst von Ihab Anwar Orabi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Thyroid Gland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction-associated fatty liver disease (MAFLD) is highly prevalent among patients with type 2 diabetes mellitus (T2DM) and is closely linked to metabolic disturbances such as insulin resistance and dyslipidemia. Thyroid hormones play a critical role in regulating hepatic lipid metabolism and energy homeostasis; however, their relationship with MAFLD in diabetic populations remains incompletely defined.

Methods

In this case-control study, 150 patients with T2DM were enrolled, including 75 patients with MAFLD and 75 without MAFLD. Hepatic steatosis was confirmed using transient elastography with controlled attenuation parameter (CAP). Serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) were measured using chemiluminescent immunoassays. Clinical, anthropometric, and biochemical parameters were assessed. Multivariate logistic regression analysis was performed to identify independent predictors of MAFLD.

Results

Patients with MAFLD had significantly lower FT3 levels and higher TSH levels compared with diabetic controls without MAFLD (p = 0.016 and p < 0.001, respectively), while FT4 levels were comparable between groups. MAFLD was also associated with an adverse metabolic profile, including elevated triglycerides, total cholesterol, and low-density lipoprotein cholesterol, along with reduced high-density lipoprotein cholesterol (all p < 0.001). Liver enzymes were significantly higher in the MAFLD group. In multivariate analysis, elevated TSH (OR = 3.62, 95% CI: 1.21-10.84, p = 0.021) and triglycerides (OR = 1.43, 95% CI: 1.14-1.80, p = 0.002) were independently associated with MAFLD, whereas FT3 was not independently associated after adjustment.

Conclusions

Elevated TSH levels are independently associated with MAFLD in patients with T2DM, suggesting a link between thyroid function and hepatic steatosis beyond traditional metabolic risk factors. These findings highlight the potential role of thyroid function, particularly TSH, in the metabolic risk stratification of patients with diabetes and warrant further investigation into thyroid-liver interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseThyroid GlandHumansCase-Control StudiesFemaleMaleMiddle AgedThyrotropinAgedThyroxineTriiodothyronine

Stichwörter der Autor:innen

Case–control studyFree triiodothyronineHepatic steatosisInsulin resistanceMetabolic dysfunction-associated fatty liver diseaseThyroid functionThyroid-stimulating hormoneType 2 diabetes mellitus

Substanzen

ThyrotropinThyroxineTriiodothyronine

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Tanta university, Tanta, Egypt.
  • Geriatric Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
  • Department of Diagnostic and Interventional Radiology and Molecular Imaging, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Internal medicine and Rheumatology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Zitieren

APA

Orabi, I. A., Elhadidy, A. A., Amro, O. A. E. A., Attia, A. A., Abdelkader, A. A., Mohamed, E. S., Alsayyad, M. M. A. A., Sakr Elfors, A. F., Abdelmalak, M. W. M., Hegab, S. M. E. A., Rashwan, T. H., Ismail, H. A. M., Hegazy, H. A., & Mashaal, S. A. (2026). Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study. La Clinica Terapeutica, 177(5), 1079-1085. https://doi.org/10.7417/ct.2026.2108

Vancouver

Orabi IA, Elhadidy AA, Amro OAEA, Attia AA, Abdelkader AA, Mohamed ES, et al. Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study. La Clinica Terapeutica. 2026;177(5):1079-1085. doi:10.7417/ct.2026.2108

BibTeX
@article{Orabi2026,
  author = {Orabi, Ihab Anwar and Elhadidy, Ahmed A and Amro, Ola Abd Elfattah Ali and Attia, Asmaa A and Abdelkader, Amr A and Mohamed, Elham Shabaan and Alsayyad, Mohammad Mossaad Abd Allah and Sakr Elfors, Ahmed Fakeih and Abdelmalak, Marian Wagieh Mansour and Hegab, Sherif Mohamed Elsayed Amin and Rashwan, Tamer Hassan and Ismail, Hatem Attia Mostafa and Hegazy, Hanan A and Mashaal, S A},
  title = {Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study},
  journal = {La Clinica Terapeutica},
  year = {2026},
  volume = {177},
  number = {5},
  pages = {1079--1085},
  doi = {10.7417/ct.2026.2108}
}
Kostenlos starten →